You just read:

Kaposi Sarcoma Market Rising to be worth US$143.2 mn by 2024; Patent Expiry of Blockbuster Drugs for Treatment of Kaposi Sarcoma to Present Lucrative Opportunities - TMR

News provided by

Transparency Market Research

12 Aug, 2016, 14:00 BST